| Renal-assessment update issued for dabigatran - TheHeart.Org |
|
|
TheHeart.Org Ingelheim am Rhein, Germany - Boehringer Ingelheim is cautioning doctors in Europe to evaluate their patients' renal function prior to treatment with dabigatran etexilate (Pradaxa) and to continue renal assessment whenever a possible decline in renal ... Boehringer Ingelheim Implements Additional Guidance Supporting Appropriate Use |